Direct thrombin inhibitor use during percutaneous coronary intervention.

@article{Kokolis2005DirectTI,
  title={Direct thrombin inhibitor use during percutaneous coronary intervention.},
  author={Spyros Kokolis and Luther T. Clark and Erdal Cavuşoğlu and Jonathan D. Marmur},
  journal={Journal of cardiovascular pharmacology},
  year={2005},
  volume={45 3},
  pages={
          270-9
        }
}
Direct thrombin inhibitors (DTI) are emerging as alternative anticoagulants to unfractionated heparin and indirect thrombin inhibitors in patients undergoing percutaneous coronary intervention (PCI). We review the pharmacological properties of these newer antithrombotic agents and evaluate the clinical data demonstrating their use in patients undergoing PCI. 

Citations

Publications citing this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 86 REFERENCES

Low-Molecular-Weight Heparins

VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

Ximelagatran-an oral direct thrombin inhibitor.

  • Progress in cardiovascular nursing
  • 2004
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

The heparin–antithrombin system: a natural anticoagulant mechanism

RD Rosenberg, KA Bauer
  • Philadelphia: JB Lippincott,
  • 1994
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

The heparin–antithrombin system: a natural anticoagulant mechanism

RD Rosenberg, KA Bauer
  • Philadelphia: JB Lippincott,
  • 1994
VIEW 11 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…